Literature DB >> 680313

Absence of true pancreatic glucagon but persistence of circulating pancreatic glucagon-like immunoreactivity after pancreatectomy in pigs.

J J Holst, M Kreutzfeldt, G Holm, E Jensen, J S Poulsen, B Sparsö, B Sparsö, A Schmidt.   

Abstract

The possible existence of circulating pancreatic type glucagon (immunoreactive glucagon as measured with a highly specific antibody) of extrapancreatic origin was investigated in 20-25 kg pigs after pancreatectomy. In intact conscious animals intravenous arginine infusions stimulated glucagon as well as insulin secretion, while blood glucose remained unaffected. Two weeks after pancreatectomy, and 48 hours after insulin withdrawal, basal glucagon and glucose concentrations were elevated (from 22 +/- 3.7 to 55 +/- 9.5 pmol/1 and 5.8 +/- 0.4 to 16.2 +/- 2.0 mmol/l, respectively), (mean +/- SEM), while insulin concentrations were either undetectable or very low. After pancreatectomy, however, glucagon concentrations no longer increased during arginine infusion. Gut type glucagon levels were not affected by pancreatectomy, and did not change during arginine infusion. When examined by gel filtration, plasma from unoperated pigs contained two components of pancreatic type glucagon, one coeluting with the glucagon marker, the other eluting earlier, probably reflecting larger molecular size. After pancreatectomy only this larger component was found in the plasma. The role of this component in the control of blood glucose is unknown.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 680313

Source DB:  PubMed          Journal:  Diabete Metab        ISSN: 0338-1684


  6 in total

1.  Glucagon and glicentin immunoreactive cells in human colon.

Authors:  P C Colony; V Helmstaedter; A J Moody; J C Garaud; W G Forssmann
Journal:  Cell Tissue Res       Date:  1982       Impact factor: 5.249

2.  Oxyntomodulin from distal gut. Role in regulation of gastric and pancreatic functions.

Authors:  B Schjoldager; P E Mortensen; J Myhre; J Christiansen; J J Holst
Journal:  Dig Dis Sci       Date:  1989-09       Impact factor: 3.199

3.  Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man.

Authors:  A Wettergren; B Schjoldager; P E Mortensen; J Myhre; J Christiansen; J J Holst
Journal:  Dig Dis Sci       Date:  1993-04       Impact factor: 3.199

4.  Circulating glucagon after total pancreatectomy in man.

Authors:  J J Holst; J H Pedersen; F Baldissera; F Stadil
Journal:  Diabetologia       Date:  1983-11       Impact factor: 10.122

5.  Glucagon levels and ketogenesis in human diabetes following total or partial pancreatectomy and severe chronic pancreatitis.

Authors:  S Del Prato; F Riva; A Devidé; R Nosadini; D Fedele; A Tiengo
Journal:  Acta Diabetol Lat       Date:  1980 Apr-Jun

6.  Functional studies in patients with the glucagonoma syndrome.

Authors:  J J Holst; S Helland; S Ingemannson; N B Pedersen; H von Schenck
Journal:  Diabetologia       Date:  1979-09       Impact factor: 10.122

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.